Authors


Stephanie Liddicoat, PhD

Latest:

Strategies to Facilitate a Positive Clinical Encounter

The counseling environment is regarded within clinical literature as having an effect on a patient’s sense of well-being.


Aditya Vaidyam, MS

Latest:

Chatbots: What Are They and Why Care?

While conversational agent technology is growing rapidly, the various technologies (chatbots) might not yet be fully equipped to help patients with clinical needs.


Sidra Qadir, MD

Latest:

Treating Patients With Comorbid Anxiety and Diabetes Mellitus

Anxiety disorders are highly prevalent in the general population, particularly in those with medical illnesses such as diabetes.


Muhammad Hasnain Abbas, MD

Latest:

Treating Patients With Comorbid Anxiety and Diabetes Mellitus

Anxiety disorders are highly prevalent in the general population, particularly in those with medical illnesses such as diabetes.


Chiara Fabbri, MD, PhD

Latest:

Overcoming Treatment Resistance: Can Pharmacogenetics Help?

Pharmacogenetic testing can provide helpful guidance in the choice of treatment and should be interpreted as a decision-support tool to assist in thoughtful implementation of good clinical care.


Kimberly Mathos, DO, MPH

Latest:

The Psychiatric Assessment of People Who Are Deaf or Hard of Hearing

Hearing loss before the development of language has a major impact on communication, identity, and social development, as well as how mental health symptoms present.


Eduardo Constantino, MD

Latest:

A Rock and a Hard Place

The costs, risks, and considerations involved in treating addiction have upped the ante, as illustrated in this case.


Melissa Palmer, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Austin R. Campbell, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Amber Finegan, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Leigh Anne Nelson, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Schuyler W. Henderson, MD, MPH

Latest:

The Limits of Advocacy

Migrant children were being endangered, with potentially devastating effects on their mental health and development, and we requested policy changes.


Lauren Broderick, MD

Latest:

Battered Woman Syndrome: Is It Enough for a Not Guilty by Reason of Insanity Plea?

Today, 25 years after the Lorena Bobbitt trial, the case has gained a renewed interest. A look back shows how far we have-and haven’t-come in conceptualizing sexual violence.


Meghan Musselman, MD

Latest:

Battered Woman Syndrome: Is It Enough for a Not Guilty by Reason of Insanity Plea?

Today, 25 years after the Lorena Bobbitt trial, the case has gained a renewed interest. A look back shows how far we have-and haven’t-come in conceptualizing sexual violence.


Elizabeth Harari, MD

Latest:

Research Sheds Light on Two Types of Treatment for ADHD

New research highlights the potential benefits and detriments of treatment strategies for ADHD, including both pharmacological and nonpharmacological options.


Vivek Datta, MD, MPH

Latest:

Introduction: Exploring the Foundations of Psychiatry

As we discover new diseases of the brain that present with psychiatric symptoms, it remains incumbent upon us to remember the experience of patients and their families in the context of society at large.


Scott Beach, MD

Latest:

Neuropsychiatry of Catatonia: Clinical Implications

As a neuropsychiatric and general medical syndrome, catatonia represents an important diagnostic and treatment challenge for all clinicians given its morbidity and mortality.


Gregory Fricchione, MD

Latest:

Mini Quiz: Malignant Catatonia

What is the best treatment for malignant catatonia, which is characterized by catatonic symptoms plus fever and hyperautonomia and is associated with significant morbidity and mortality? Take the quiz.


Gertie Quitangon, MD

Latest:

Managing Distress in Health Care Workers During COVID-19: Lessons From a Disaster Trauma Lens

We have learned that in order to provide much-needed social support during difficult times, organizations should prepare to take certain steps.


Ken Duckworth, MD

Latest:

Helping Complex Patients

The National Alliance on Mental Illness (NAMI) is a one-of-a-kind nonprofit that is here for your patients and their families, no matter where they are.


Christine Allen

Latest:

Helping Complex Patients

The National Alliance on Mental Illness (NAMI) is a one-of-a-kind nonprofit that is here for your patients and their families, no matter where they are.


Benjamin Tolchin, MD, MS

Latest:

Mini Quiz: The Truth About Psychogenic Nonepileptic Seizures

PNES cause significant suffering, and most patients with undiagnosed and/or untreated PNES continue to have seizures and remain on disability. What do we know about PNES? Take the quiz and learn more.


Hamada Altalib, DO, MPH

Latest:

Addressing Psychogenic Nonepileptic Seizures: Clinical Challenges

DSM-5 categorizes PNES as a functional neurological disorder or conversion disorder with seizures. It is essential that neurologists, psychiatrists, and other clinicians coordinate care to ensure that patients with PNES receive a prompt diagnosis.


Carissa Cabán-Alemán, MD

Latest:

Puerto Rico Se Levanta (“Puerto Rico Rises”): From Denial and Passivity to Action and Hope

Hurricane Maria was the wakeup call many Puerto Ricans needed to become active in social justice efforts. Their story serves as an example of transformational resilience.


Coreen B. Domingo, DrPH

Latest:

Cannabinoids for Chronic Pain: An Opioid Alternative?

The cannabinoids (particularly CBD) have been hailed as non-addictive solutions to using escalating doses of opioids for chronic pain. More in this research update.


Jonathan R. Scarff, MD

Latest:

How Can Psychiatrists Become Better Negotiators?

Use these strategies to facilitate beneficial outcomes for patients, improve relationships with colleagues, and enhance workplace satisfaction.


Joseph R. Sanok, MA, LLP, LPC, NCC

Latest:

Making Your Practice Work for You

By releasing old assumptions and brainstorming, it is possible to break the old models of private practice and find new ways to be productive within your practice.


Amresh Shrivastava, MD

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.


Avinash De Sousa, MD

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.


Pragya Lodha, MA

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.

© 2024 MJH Life Sciences

All rights reserved.